Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

A New European Consortium to Boost our Understanding of IBD

Published: Thursday, May 23, 2013
Last Updated: Thursday, May 23, 2013
Bookmark and Share
A multi-modal integrated biomarker study Consortium to increase diagnostic precision in detection of the diseases.

The Inflammatory Bowel Disease Characterization by a multi-modal integrated biomarker study (IBD-Character) Consortium is a collaborative effort to advance our understanding of the inflammatory bowel diseases Ulcerative Colitis and Crohn's Disease and to increase diagnostic precision in detection of the diseases in their early manifestation.

The consortium associates 10 European partners from both academia and industry. It starts with a € 6M grant thanks to the European Commission´s 7th Framework Program (FP7).

The project will generate the largest collection of samples so far assembled from treatment naïve patients recently diagnosed with inflammatory bowel disease.

DNA methylation and RNA transcription status, protein markers, gut microbial content, patient genotype for known susceptibility loci and classical clinical data will be extensively analyzed for the characterization of the cohort in order to create a molecular snapshot of IBD in its early manifestation.

This massive molecular profiling will be used to yield a list of biomarkers indicative for onset of the disease.

The participating Small and Medium sized Enterprises (SMEs) will develop assays capable of analyzing panels of several hundred relevant protein markers as well as methods for rapid profiling of gut microbial content relevant for IBD.

The proposed biomarkers will form a solid ground for development of improved diagnostic assays and be a rich source to mine for novel therapeutic targets.

"We are pleased to have gathered such a strong combination of clinicians, clinical researchers, basic researchers and innovative SME:s into one focused project," said Dr. Mats Gullberg, project coordinator for IBD-Character and Chief Technology Officer at Olink Bioscience.

Dr. Gullberg continued, "The project will advance our understanding of IBD as well as generate proprietary products by the participating SMEs. The project will provide the most complete molecular characterization of samples from patients with IBD and also progress the field of analysis of large data sets containing different types of molecular markers from large sets of individuals."

Based on the findings within the IBD-Character project, results are expected to improve many aspects of patient care, including the development of new personalized medical strategies and treatments.

Consortium members

The project will be co-ordinated by Olink Bioscience (Sweden) with partners coming from several European countries including the United Kingdom, Sweden, Belgium, Spain and Norway.

The IBD-Character Consortium unites researchers from three SME:s, one research institute, five Universities and one public, non-profit organization.

IBD-Character is a four year project running from the 1st of December 2012 until the 30th of November 2016 and is funded by the 7th Framework Program of the European Commission. In addition to the research activities, IBD-Character will be organizing meetings, workshops and will be present at a number of international conferences.

Members of the consortium:
• Olink Bioscience (Coordinator, SME), Mats Gullberg, SE
• Diagenode (SME), Hélène Pendeville, BE
• Genetic Analsysis (SME), Heidi Vebø, NO
• Instituto Aragonés de Ciencias de la Salud/IIS Aragón, Fernando Gomollón, ES
• Linköpings Universitet, Johan Söderholm, Åsa Keita SE
• The University of Edinburgh, Jack Satsangi, UK
• Örebro University Hospital, Jonas Halfvarson, SE
• Centro Nacional de Análisis Genómico, Ivo Gut, Monica Bayés, ES
• Karolinska Institutet, Mauro D’Amato, SE
• Universitetet I Oslo, Morten H. Vatn, Bettina Kulle Andreassen, NO


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Olink Bioscience Appoints Sigma-Aldrich as Distributor of Duolink
Olink Bioscience will continue to develop the protein biomarker market.
Friday, May 17, 2013
Olink Bioscience Appoints Simon Fredriksson Ph.D. as Executive Vice President
With the new appointment follow increased responsibilities for global business development and external research collaborations.
Monday, June 20, 2011
Olink Bioscience and Sapphire Bioscience Sign a Distributorship Agreement for the Australian & New Zealand Market
Agreement with Sapphire Bioscience for the distribution of the Duolink® product line in Australia and New Zealand.
Wednesday, April 06, 2011
Olink Bioscience and Pioneer Biomed Sign Distributorship Agreement for the Chinese Market
The agreement covers distribution of Duolink regent kit based on PLA® technology.
Monday, March 08, 2010
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Designing Drugs with a Whole New Toolbox
Researchers develop methods to design small, targeted proteins with shapes not found in nature.
Protein Studies Discover Molecular Secrets
Two protein studies have mapped proteins that reveal the secrets to recycling carbon and healing cells.
Tapping Evolution to Improve Biotech Products
Researchers show how 'ancestral sequence reconstruction' can be used to guide engineering of a blood clotting protein.
New Weapon Against Hard-to-Treat Bacterial Infections
Using peptides, researchers have been able to prevent drug-resistance bacteria from forming abscesses.
Death-or-Repair Switch Protein Identified
Researchers have identified a protein that plays a key role in the decision process of cell damage repair or cellular suicide.
Gene Regulation in Brain May Explain Repetitive Behaviors in Rett Syndrome Patients
The research could be a key step in developing treatments to eliminate symptoms that drastically impair the quality of life in Rett patients.
CES Score May Predict Response to Cancer Treatment
Researchers identify new type of biomarker that helps predict prognosis and response to several types of cancer treatment.
Gene Deletion Reveals Cell Secrets
Researchers have deleted 174 genes in yeast to analyse the effect of individual gene deletion.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!